Avalo Therapeutics Inc
Biotechnology
Healthcare
AVTX
10.78 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
5.43
52 week high
14.44
high
5.44
52 week low
5.10
previous Close
5.49
P/E ratio
-4
market cap
93.23 M
div yield
0
net incoming
23.04 M
-76.60 %
net profit margin
9251.81 %
9251.00 %
operating incoming
-12.86 M
-35.78 %
net change in cash
-11.53 M
31.20 %
cash on hand
81.86 M
-12.38 %
cost of revenue
-714.00 K
-308.16 %
top